Centre for Clinical Brain Sciences

Dr Suvankar Pal

Dr Suvankar Pal is a Consultant Neurologist & Research Fellow who is interested in the diagnosis, audit, research and treatment of people with cognitive disorders.

Dr Suvankar Pal (BSc(Hons) MBBS(Dist) MRCP(Neurol) MD(Res) PGCME FHEA)

Consultant Neurologist & NHS Research Scotland Career Research Fellow

  • Centre for Clinical Brain Sciences
  • Anne Rowling Regenerative Neurology Clinic
  • Euan MacDonald Centre for Motor Neurone Disease Research

Contact details


  • 2012 – present: Principal Investigator for Edinburgh Cognitive Disorders Diagnosis Audit Research & Treatment Study
  • 2012: NHS Research Scotland Career Research Fellow
  • 2011: Consultant Neurologist, Forth Valley Royal Hospital and Department of Clinical Neurosciences, Edinburgh
  • 2007-2011: Higher Specialist Training in Neurology, Department of Clinical Neurosciences Edinburgh
  • 2004-2007: Clinical Research Fellow, MRC Prion Unit & National Prion Clinic, Department of Neurodegenerative Diseases, Institute of Neurology/National Hospital for Neurology Queen Sq, London. MD Thesis “Investigation of novel diagnostic strategies in prion disease”
  • 2002-2004: Royal Postgraduate Medical Rotation (Hammersmith Hospital & National Hospital for Neurology, London)
  • 2001: MBBS (with Distinction in Clinical Sciences) King’s College London
  • 1998: BSc in Neurosciences, King’s College London (Wolfson Scholar)

Research aims & areas of interest

Neurodegenerative diseases causing dementia are progressive, untreatable and usually fatal disorders which represent a major public health threat. Dementia has been identified by the United Kingdom government as a national clinical and research priority.

We have established the Edinburgh Cognitive Diagnosis Audit Research and Treatment (ECOG DART) register to deliver a mutliprofessional approach to longitudinal investigation of diagnosis, assessment, investigation and progression in patients with cognitive symptoms.

The research register prospectively records accurate clinical and novel data sets necessary to enable translational research in the context of a longitudinal clinical cohort study including, deep clinical phenotyping, computerised cognitive testing, evaluation of novel diagnostic clinical neuropsychological tests, diagnostic neurodegenerative gene set analysis, cerebrospinal fluid (CSF) biomarkers and investigation of novel diagnostic structural (MRI) and functional (SPECT/PET) neuroimaging studies.

The register also maintains a database of people who have consented to their details being held for inclusion in collaborative research studies (including clinical trials). Affiliated tissue banks archiving DNA, CSF and skin fibroblast samples further support collaborative research.


  • Professor Mary Porteous, Director South East Scotland Genetics Service, The Centre for Molecular Medicine, University of Edinburgh
  • Dr Jenny Barnett, Director of Science & Innovation, Cambridge Cognition
  • Dr Zubair Khan, Department of Nuclear Medicine & Radiology, NHS Lothian

Sources of funding

  • NHS Research Scotland